VAERS Explorer
Back to explore

Report #2855314

Received Aug 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
18 yrs
State
TX
Recovered
Unknown
Vaccinated
Jul 7, 2025
Onset
Jul 7, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.1Y014323OT

Symptoms (1)

Incorrect dose administered

Symptom narrative

No symptoms reported; HCP reports an 18 year old patient received a larger than recommended dose of RECOMBIVAXHB on 07JUL2025. This was the patient's first dose and patient was administered 1.0mL. No symptoms reported. HCP provided consent to correspondence. No add; This spontaneous report was received from a medical assistant and refers to an 18-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 07-Jul-2025, the patient was vaccinated with the first dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) (lot #Y014323, expiration date: 12-Feb-2027) 1 mL administered by Unknown route as Prophylaxis. The reporter stated that the patient received a larger than recommended dose (Overdose). No symptoms reported.